FIELD: medicine.
SUBSTANCE: invention refers to medicine. A method of treating the patients with the complicated forms of diabetic foot by blood sampling, centrifugation, plasma removal, erythrocyte fraction recovery, introduction of the angiotropic drug alprostadil, exposure to laser light at power 12 mWt for 20 minutes, addition of normal saline 100 ml in erythrocyte fraction 200 ml and reinfusion for 1.5-2 hours; ATP 2 ml is combined with the angiotropic drug alprostadil and introduced into the erythrocyte fraction; the erythrocyte fraction is reinfused every second day, alternated with intravenous drop-by-drop introduction of Vessel-DUE-F 600 LSU and actovegin 5 ml per normal saline 100 ml; the therapeutic course is 10 days.
EFFECT: using the method provides higher effectiveness and reduces the length of treatment of the patients with the complicated forms of diabetic foot syndrome, promotes the longer preservation of the achieved therapeutic effect.
Title | Year | Author | Number |
---|---|---|---|
METHOD OF COMPLEX TREATMENT OF PATIENTS WITH PURULENT-NECROTIC FORMS OF DIABETIC FOOT SYNDROME | 2013 |
|
RU2553203C1 |
METHOD OF COMPLEX TREATMENT OF PATIENTS WITH PURULONECROTIC COMPLICATIONS OF DIABETIC FOOT SYNDROME | 2020 |
|
RU2737491C1 |
WAY OF TREATMENT OF ARTERIES OF LOWER LIMBS AT PATIENTS WITH OBLITERATING ATHEROSCLEROSIS | 2007 |
|
RU2363499C2 |
METHOD OF TREATMENT OPERATED PATIENTS WITH DIABETIC FOOT SYNDROME | 2015 |
|
RU2605286C1 |
METHOD FOR COMBINED TREATMENT OF III-IV DEGREE CHRONIC ARTERIAL INSUFFICIENCY OF LOWER EXTREMITIES | 2018 |
|
RU2718287C1 |
METHOD FOR TREATING NEUROISCHEMIC DIABETIC FOOT SYNDROME | 2020 |
|
RU2754415C1 |
METHOD OF TREATING NEUROPATHIC TROPHIC ULCERS ACCOMPANYING DIABETIC FOOT | 2013 |
|
RU2549459C2 |
THERAPY OF CHRONIC LOWER LIMB ISCHEMIA | 2008 |
|
RU2367477C1 |
THERAPY OF SECONDARY LOWER LIMB LYMPHODEMA | 2007 |
|
RU2356587C1 |
METHOD FOR REDUCING BLOOD GLUCOSE IN PATIENTS WITH DIABETES MELLITUS COMPLICATED BY DIABETIC FOOT | 2019 |
|
RU2704977C1 |
Authors
Dates
2014-01-20—Published
2010-01-29—Filed